Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06426836 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Study acronym: PADECMO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years later Jul 1, 2026 → Jul 1, 2029
See other at-risk trials from University Hospital, Ghent

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 1, 2026 to Jul 1, 2029 Show 4 more changesShow less
    • Primary endpoints: details revised at 14 of 17 entries
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 11 of 11 entries
    • Site details revised at 1 of 3 sites
  2. Primary completion date: Dec 1, 2025 to Jul 1, 2026
    • Site details revised at 1 of 3 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).
Trial Details
NCT Number NCT06426836
Lead Sponsor University Hospital, Ghent
Conditions
(from sponsor)		 Pharmacokinetics, Amoxicillin-clavulanate, Piperacillin-tazobactam, Meropenem, Cefazolin, Teicoplanin, Vancomycin, Ciprofloxacin +1 more
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov